Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Japan Animal Referral Medical Center Co., Ltd. (6039.T)
Kawasaki, JP
Japan Animal Referral Medical Center Co., Ltd. operates a network of animal medical facilities across Japan, specializing in delivering advanced veterinary care for dogs and cats. These comprehensive centers boast an extensive range of specialized departments, from cardiology, respiratory, urology, and gastroenterology to oncology, neurology, orthopedics, ophthalmology, diagnostic imaging, and anesthesiology. Beyond direct patient care, the company also offers professional training, encompassing clinical instruction and treatment practices. Furthermore, it actively engages in research and development initiatives, exploring fields such as genetic testing, immunotherapy, and regenerative medicine. The firm, established in 2005, has its headquarters located in Kawasaki, Japan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -18.51% | -24.61% | -35.43% | -26.09% | -12.02% | -11.49% | +103.97% | +185.19% | +164.57% | +199.12% | +210.06% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Personal Products & Services: +6.6%+17.3% ★ Q1'26: +14.7% (vs Q1'25)
-
EPS growth Personal Products & Services: +19.6%+60.5% ★ Q1'26: +41.5% (vs Q1'25)
-
FCF margin FCF growth · Personal Products & Services: +11.7%+12.7% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Personal Products & Services: +10.5%+18.6% ★ Q1'26: +12.0% (vs Q1'25)
-
ROIC Personal Products & Services: +6.9%+9.9% ★ Q1'26: +7.7% (vs Q1'25)
-
Share dilution Personal Products & Services: +0.0%-0.3% ★ Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Personal Products & Services: 0.59×2.97× Q1'26: 3.88× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.19B
est: 2.20B (-0.4%)
|
2.26B
est: 2.38B (-5.1%)
|
2.56B
est: 2.58B (-0.6%)
|
2.73B
est: 2.67B (+2.4%)
|
2.85B
est: 2.84B (+0.3%)
|
2.98B
est: 2.95B (+1.0%)
|
3.87B
est: 3.86B (+0.3%)
|
4.27B
est: 4.39B (-2.7%)
|
5.28B
est: 5.20B (+1.5%)
|
6.20B
6.20B – 6.20B
+19.2% YoY
|
6.70B
6.70B – 6.70B
+8.1% YoY
|
7.20B
7.20B – 7.20B
+7.5% YoY
|
| EBITDA |
496.36M
est: 521.20M (-4.8%)
|
456.63M
est: 563.84M (-19.0%)
|
621.50M
est: 611.22M (+1.7%)
|
648.63M
est: 632.54M (+2.5%)
|
625.58M
est: 672.82M (-7.0%)
|
680.27M
est: 698.88M (-2.7%)
|
996.73M
est: 914.46M (+9.0%)
|
961.39M
est: 1.03B (-6.8%)
|
1.29B
est: 1.22B (+5.7%)
|
1.46B
1.46B – 1.46B
+19.2% YoY
|
1.57B
1.57B – 1.57B
+8.1% YoY
|
1.69B
1.69B – 1.69B
+7.5% YoY
|
| EBIT |
294.30M
est: 309.38M (-4.9%)
|
279.96M
est: 334.69M (-16.4%)
|
397.23M
est: 362.82M (+9.5%)
|
430.69M
est: 375.48M (+14.7%)
|
405.54M
est: 399.38M (+1.5%)
|
439.27M
est: 414.85M (+5.9%)
|
584.89M
est: 542.82M (+7.8%)
|
496.92M
est: 609.20M (-18.4%)
|
720.98M
est: 721.61M (-0.1%)
|
860.38M
860.38M – 860.38M
+19.2% YoY
|
929.76M
929.76M – 929.76M
+8.1% YoY
|
999.15M
999.15M – 999.15M
+7.5% YoY
|
| Net Income |
229.41M
est: 277.00M (-17.2%)
|
208.09M
est: 293.08M (-29.0%)
|
294.93M
est: 364.40M (-19.1%)
|
312.82M
est: 330.69M (-5.4%)
|
285.19M
est: 298.01M (-4.3%)
|
286.94M
est: 337.95M (-15.1%)
|
380.66M
est: 406.42M (-6.3%)
|
337.22M
est: 456.74M (-26.2%)
|
520.98M
est: 499.39M (+4.3%)
|
899.52M
899.52M – 899.52M
+80.1% YoY
|
1.00B
1.00B – 1.00B
+11.2% YoY
|
1.05B
1.05B – 1.05B
+4.9% YoY
|
| SGA |
432.14M
est: 432.52M (-0.1%)
|
424.66M
est: 467.91M (-9.2%)
|
450.14M
est: 507.23M (-11.3%)
|
501.33M
est: 524.93M (-4.5%)
|
511.95M
est: 558.35M (-8.3%)
|
574.00M
est: 579.98M (-1.0%)
|
754.36M
est: 758.88M (-0.6%)
|
859.90M
est: 839.95M (+2.4%)
|
992.58M
est: 994.93M (-0.2%)
|
1.19B
1.19B – 1.19B
+19.2% YoY
|
1.28B
1.28B – 1.28B
+8.1% YoY
|
1.38B
1.38B – 1.38B
+7.5% YoY
|
| EPS |
19.62
est: 21.36 (-8.1%)
|
17.53
est: 22.60 (-22.4%)
|
24.41
est: 28.10 (-13.1%)
|
25.76
est: 25.50 (+1.0%)
|
24.15
est: 22.98 (+5.1%)
|
24.19
est: 26.06 (-7.2%)
|
31.27
est: 31.34 (-0.2%)
|
24.60
est: 35.22 (-30.2%)
|
40.22
est: 38.64 (+4.1%)
|
69.60
69.60 – 69.60
+80.1% YoY
|
77.40
77.40 – 77.40
+11.2% YoY
|
81.20
81.20 – 81.20
+4.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-05-14 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-05-13 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-05-12 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-05-11 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-05-08 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-05-07 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-05-01 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-30 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-28 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-27 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-24 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-23 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-22 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-21 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-20 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-17 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-16 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - International Core Equity 2 ETF DFIC | 0.00% | 84.8K | 0.22% |
| 2 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 42.5K | 0.28% |
| 3 | Dimensional - International Small Cap ETF DFIS | 0.00% | 9.8K | 0.39% |
| 4 | Dimensional - International Core Equity Market ETF DFAI | 0.00% | — | 0.18% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hidehiro Hirao | President, Chief Executive Officer & Chairman | — | male |
| Satoru Matsunaga | Director | — | male |
| Takayuki Ishikawa | General Manager of Administrative Division | — | male |
| Yu Kawai | Head of Internal Audit Department | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 6039.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
